(Q46681328)

24 December 2017

title

Interim report of toxicity from 3D conformal radiation therapy (3D-CRT) for prostate cancer on 3DOG/RTOG 9406, level III (79.2 Gy). (English)

1 reference

24 December 2017

adaptive radiation therapy

main subject

0 references

1 reference

8

Mack Roach

1 reference

24 December 2017

author name string

Janice K Ryu

1

1 reference

24 December 2017

Kathryn Winter

2

1 reference

24 December 2017

Jeff M Michalski

3

1 reference

24 December 2017

James A Purdy

4

1 reference

24 December 2017

Arnold M Markoe

5

1 reference

24 December 2017

John D Earle

6

1 reference

24 December 2017

Carlos A Perez

7

1 reference

24 December 2017

Howard M Sandler

9

1 reference

24 December 2017

Alan Pollack

10

1 reference

24 December 2017

James D Cox

11

1 reference

24 December 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

24 December 2017

International Journal of Radiation Oncology Biology Physics

published in

1 reference

24 December 2017

volume

54

1 reference

24 December 2017

issue

4

1 reference

24 December 2017

page(s)

1036-1046

1 reference

24 December 2017

The effect of dose on local control of prostate cancer.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903006-7

7 January 2021

Tumor control in definitive irradiation of localized carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903006-7

7 January 2021

Dose selection for prostate cancer patients based on dose comparison and dose response studies

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903006-7

7 January 2021

Matched-pair analysis of conformal high-dose-rate brachytherapy boost versus external-beam radiation therapy alone for locally advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903006-7

7 January 2021

3D conformal radiation therapy (3DCRT) for high grade prostate cancer: a multi-institutional review

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903006-7

7 January 2021

Optimization of conformal radiation treatment of prostate cancer: Report of a dose escalation study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903006-7

7 January 2021

Three dimensional conformal radiotherapy for the treatment of prostate cancer: Low risk of chronic rectal morbidity observed in a large series of patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903006-7

7 January 2021

Late GI and GU complications in the treatment of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903006-7

7 January 2021

External beam radiotherapy dose response of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903006-7

7 January 2021

Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903006-7

7 January 2021

Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903006-7

7 January 2021

Re: The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903006-7

7 January 2021

Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903006-7

7 January 2021

Limitations of reduced-field irradiated volume and technique in conventional radiation therapy of prostate cancer: implications for conformal 3-D treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903006-7

7 January 2021

Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903006-7

7 January 2021

Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903006-7

7 January 2021

Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903006-7

7 January 2021

Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903006-7

7 January 2021

Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: Further evidence for a significant dose effect

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903006-7

7 January 2021

Dose escalation with 3D-CRT in prostate cancer: French study of dose escalation with conformal 3D radiotherapy in prostate cancer-preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903006-7

7 January 2021

Toxicity following high-dose three-dimensional conformal and intensity-modulated radiation therapy for clinically localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903006-7

7 January 2021

10.1016/S0360-3016(02)03006-7

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/j4ba3g6e6nhcbef2rjqnutl444

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_j4ba3g6e6nhcbef2rjqnutl444

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/j4ba3g6e6nhcbef2rjqnutl444

30 July 2022

mapped directly with Wikidata item

https://api.fatcat.wiki/v0/release/j4ba3g6e6nhcbef2rjqnutl444

1 reference

30 July 2022